弥合心脏衰竭的差距 科学:朝着更完整的未来
Ju-Chi Liu1,2, Tzu-Hurng Cheng3
1Division of Cardiology, Department of Internal Medicine, Shuang Ho Hospital, Ministry of Health and Welfare, Taipei Medical University, New Taipei City 23561, Taiwan.
Life (Basel, Switzerland)
|October 29, 2025
概括
心力衰竭是全球主要的健康问题,影响着数百万人. 这项研究调查了其影响和潜在的解决方案,以改善患者的治疗结果和减少医疗保健负担.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 是一个关键的全球健康挑战.
- HF显著影响患者的生活质量和生存率.
- 高频对医疗保健系统的经济负担很大.
研究的目的:
- 分析目前心力衰竭的现状.
- 确定高频管理中的关键挑战.
- 探索创新的策略,以改善HF护理.
主要方法:
- 系统的文献审查.
- 对流行病学数据的分析.
- 对治疗疗效的元分析.
主要成果:
- 在全球范围内,HF的发病率和流行率正在增加.
- 某些并发症与较差的HF结局有关.
- 早期诊断和综合护理模型显示出有希望的结果.
结论:
- 心力衰竭需要紧急和全面的管理策略.
- 多学科的方法对于最佳的患者护理至关重要.
- 对新型治疗干预措施的进一步研究是有必要的.
相关概念视频
Heart Failure II: Pathophysiology
704
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
704
Pathophysiology of Heart Failure
2.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.8K
Heart Failure I: Introduction
676
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
676
Heart Failure V: Medical Management
209
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
209
Heart Failure VI: Adjunct Therapies
246
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
246
Heart Failure IV: Classification and Diagnostic Evaluation
313
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
313


